Global Health
From Lab to Field: Progress in Crimean-Congo Haemorrhagic Fever Testing
In the ongoing fight against Crimean-Congo Haemorrhagic Fever (CCHF), Global Access Diagnostics (GADx) has joined forces with the Liverpool School of Tropical Medicine and international experts to develop a rapid diagnostic test (RDT) tailored for…
Rapid Diagnostics for a Better World – POCT Leipzig Insights
Dr. Kevin Land, the Head of Innovative Research and Development at Global Access Diagnostics (GADx), delivered a compelling keynote at the prestigious POCT Leipzig conference on April 17, 2024. The event, hosted by the Fraunhofer…
Innovating Epidemic Surveillance: GADx partners on HOLICARE
GADx, in partnership with an international consortium, is revolutionising healthcare in low- and middle-income countries through the HOLICARE project. HOLICARE is a groundbreaking initiative established to improve the diagnosis of respiratory tract infections (RTIs), addressing…
GADx acquires manufacturing rights for IT LEISH rapid diagnostic test from Bio-Rad Laboratories
Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics and driving local manufacturing, today announced it has acquired the manufacturing rights for the IT LEISH rapid diagnostic test (RDT) for visceral leishmaniasis…
Mologic to become a ‘Social Enterprise’ after acquisition by social impact funders and investors
A group of philanthropic funds and investors led by the Soros Economic Development Fund (SEDF), with support from the Bill & Melinda Gates Foundation, is today announcing the launch of Global Access Health (GAH), a…